These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33668925)

  • 1. Variation, Modification and Engineering of Lipid A in Endotoxin of Gram-Negative Bacteria.
    Kawahara K
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The structural diversity of lipid A from gram-negative bacteria].
    Lodowska J; Wolny D; Weglarz L; Dzierzewicz Z
    Postepy Hig Med Dosw (Online); 2007; 61():106-21. PubMed ID: 17369779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis, transport, and modification of lipid A.
    Trent MS
    Biochem Cell Biol; 2004 Feb; 82(1):71-86. PubMed ID: 15052329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kdo2 -lipid A: structural diversity and impact on immunopharmacology.
    Wang X; Quinn PJ; Yan A
    Biol Rev Camb Philos Soc; 2015 May; 90(2):408-27. PubMed ID: 24838025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for the analysis of amide-linked hydroxy fatty acids in lipid-As from gram-negative bacteria.
    Bhat UR; Carlson RW
    Glycobiology; 1992 Dec; 2(6):535-9. PubMed ID: 1472760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl-acyl carrier protein specificity of UDP-GlcNAc acyltransferases from gram-negative bacteria: relationship to lipid A structure.
    Williamson JM; Anderson MS; Raetz CR
    J Bacteriol; 1991 Jun; 173(11):3591-6. PubMed ID: 1904441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide: Biosynthetic pathway and structure modification.
    Wang X; Quinn PJ
    Prog Lipid Res; 2010 Apr; 49(2):97-107. PubMed ID: 19815028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generation of vaccine strains of gram-negative bacteria with reduced adverse reactions].
    Dentovskaia SV; Shaĭhutdinov RZ; Knirel' IuA; Ivanov SA; Anisimov AP
    Mol Gen Mikrobiol Virusol; 2006; (2):3-8. PubMed ID: 16755996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, Function and Biological Activity of Lipopolysaccharide Lipid A.
    Varbanets LD
    Mikrobiol Z; 2016; 78(6):37-49. PubMed ID: 30141882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid A modification systems in gram-negative bacteria.
    Raetz CR; Reynolds CM; Trent MS; Bishop RE
    Annu Rev Biochem; 2007; 76():295-329. PubMed ID: 17362200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilms formed by gram-negative bacteria undergo increased lipid a palmitoylation, enhancing in vivo survival.
    Chalabaev S; Chauhan A; Novikov A; Iyer P; Szczesny M; Beloin C; Caroff M; Ghigo JM
    mBio; 2014 Aug; 5(4):. PubMed ID: 25139899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the unusual acylation pattern of Helicobacter pylori lipid A.
    Stead CM; Beasley A; Cotter RJ; Trent MS
    J Bacteriol; 2008 Nov; 190(21):7012-21. PubMed ID: 18757539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of endotoxin and its impact on pathogenesis.
    Trent MS; Stead CM; Tran AX; Hankins JV
    J Endotoxin Res; 2006; 12(4):205-23. PubMed ID: 16953973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical structure and biologic activity of bacterial and synthetic lipid A.
    Rietschel ET; Brade L; Brandenburg K; Flad HD; de Jong-Leuveninck J; Kawahara K; Lindner B; Loppnow H; Lüderitz T; Schade U
    Rev Infect Dis; 1987; 9 Suppl 5():S527-36. PubMed ID: 3317748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis and structure-activity relationships of the lipid a family of glycolipids.
    Xiao X; Sankaranarayanan K; Khosla C
    Curr Opin Chem Biol; 2017 Oct; 40():127-137. PubMed ID: 28942130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-negative endotoxin: a biologically active lipid.
    Raetz CR; Brozek KA; Clementz T; Coleman JD; Galloway SM; Golenbock DT; Hampton RY
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 2():973-82. PubMed ID: 2474409
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharide.
    Zariri A; Pupo E; van Riet E; van Putten JP; van der Ley P
    Sci Rep; 2016 Nov; 6():36575. PubMed ID: 27841285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemical structure of bacterial endotoxin in relation to bioactivity.
    Rietschel ET; Kirikae T; Schade FU; Ulmer AJ; Holst O; Brade H; Schmidt G; Mamat U; Grimmecke HD; Kusumoto S
    Immunobiology; 1993 Apr; 187(3-5):169-90. PubMed ID: 8330896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic manipulation of nonenteric bacterial pathogens to synthesise altered lipopolysaccharide molecules.
    Maskell D; Allen A; Khan S; Servos S
    Prog Clin Biol Res; 1995; 392():35-47. PubMed ID: 8524941
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural analysis of the lipid A component of Campylobacter jejuni CCUG 10936 (serotype O:2) lipopolysaccharide. Description of a lipid A containing a hybrid backbone of 2-amino-2-deoxy-D-glucose and 2,3-diamino-2,3-dideoxy-D-glucose.
    Moran AP; Zähringer U; Seydel U; Scholz D; Stütz P; Rietschel ET
    Eur J Biochem; 1991 Jun; 198(2):459-69. PubMed ID: 2040305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.